silybin has been researched along with Metastase in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Fan, J; Gao, Y; Guo, P; He, D; Li, L; Ning, Z; Wang, B; Wang, X; Wu, K; Zeng, J; Zhang, L; Zhang, T; Zhou, J | 1 |
| Agarwal, C; Agarwal, R; Deep, G; Jain, AK; Kumar, R | 1 |
| Chang, YC; Hu, FW; Jan, CI; Lai, YC; Peng, CY; Yu, CC | 1 |
| Li, YP; Meng, QS; Su, JH; Sun, HP; Wang, SL; Yin, Q; Yu, HJ; Zhang, PC; Zhang, ZW | 1 |
| Agarwal, R; Raina, K; Sharma, G; Singh, RP | 1 |
| Fan, J; He, D; Li, L; Wang, X; Wu, K; Xue, Y; Yang, L; Zeng, J; Zhang, D; Zhu, G | 1 |
| Agarwal, R; Deep, G | 1 |
| Azadmanesh, K; Dastpeyman, M; Jahanian-Najafabadi, A; Kia, V; Mostafavi, E; Motamed, N; Shokrgozar, MA | 1 |
| Gardner, TR; Grieco, M; Herath, SA; Jang, JH; Kirchoff, D; Naffouje, S; Njoh, L; Shantha Kumara, HM; Whelan, RL; Yan, X | 1 |
| Chen, PN; Chiang, CL; Chiou, HL; Chu, SC; Hsieh, YS; Yang, SF | 1 |
1 review(s) available for silybin and Metastase
| Article | Year |
|---|---|
Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer.
Topics: Animals; Antioxidants; Humans; Neoplasm Metastasis; Neoplasms; Signal Transduction; Silybin; Silybum marianum; Silymarin | 2010 |
9 other study(ies) available for silybin and Metastase
| Article | Year |
|---|---|
Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
Topics: Animals; Anticarcinogenic Agents; beta Catenin; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Homeodomain Proteins; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplastic Stem Cells; Signal Transduction; Silybin; Silybum marianum; Silymarin; Transcription Factors; Urinary Bladder; Urinary Bladder Neoplasms; Zinc Finger E-box-Binding Homeobox 1 | 2013 |
Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Delivery Systems; Extracellular Matrix; Fibronectins; Humans; Integrins; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Prostatic Neoplasms; Signal Transduction; Silybin; Silymarin; Xenograft Model Antitumor Assays | 2014 |
Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.
Topics: AC133 Antigen; ADAM Proteins; ADAM10 Protein; Aldehyde Dehydrogenase 1 Family; Amyloid Precursor Protein Secretases; Animals; Antigens, CD; Carcinoma, Squamous Cell; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Glycoproteins; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Incidence; Isoenzymes; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplastic Stem Cells; Peptides; Phenotype; Polycomb Repressive Complex 1; Prognosis; Retinal Dehydrogenase; Silybin; Silymarin | 2015 |
Silibinin and indocyanine green-loaded nanoparticles inhibit the growth and metastasis of mammalian breast cancer cells in vitro.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Liberation; Female; Humans; Indocyanine Green; Nanoparticles; Neoplasm Metastasis; Particle Size; Silybin; Silymarin; Wound Healing | 2016 |
Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Blotting, Western; Cadherins; Cell Proliferation; Disease Progression; Immunohistochemistry; Male; Matrix Metalloproteinases; Mice; Mice, Transgenic; Neoplasm Metastasis; Neovascularization, Pathologic; Prostatic Neoplasms; Silybin; Silymarin; Vimentin | 2008 |
Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.
Topics: Antioxidants; Blotting, Western; Cell Adhesion; Cell Line; Cell Movement; Cell Proliferation; Down-Regulation; Epithelial Cells; Fluorescent Antibody Technique; Humans; Keratin-18; Male; Matrix Metalloproteinase 2; Mesoderm; Neoplasm Metastasis; NF-kappa B; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Silybin; Silymarin; Transcription Factors; Up-Regulation; Vimentin | 2010 |
Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI.
Topics: Antioxidants; Breast Neoplasms; cdc42 GTP-Binding Protein; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Integrin beta1; Neoplasm Metastasis; Proto-Oncogene Proteins c-raf; rho Guanine Nucleotide Dissociation Inhibitor beta; RNA, Messenger; Silybin; Silymarin | 2012 |
Perioperative polyphenon E- and siliphos-inhibited colorectal tumor growth and metastases without impairment of gastric or abdominal wound healing in mouse models.
Topics: Abdomen; Analysis of Variance; Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Collagen; Colorectal Neoplasms; Drug Combinations; Female; Laparotomy; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasm Transplantation; Perioperative Period; Pneumoperitoneum, Artificial; Pressure; Random Allocation; Silybin; Silymarin; Stomach; Surgical Wound Dehiscence; Wound Healing | 2012 |
Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Carcinoma, Squamous Cell; Cell Line, Tumor; Humans; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Metastasis; Protease Inhibitors; Silybin; Silymarin; Tongue Neoplasms; Urokinase-Type Plasminogen Activator | 2006 |